Biosino Bio-Technology and Science Inc
08247
Company Profile
Business description
Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale and distribution of IVD reagent products. The company operates in single segment the in-vitro diagnostic reagent products segment, which manufactures, sells and distributes a variety of mono/double diagnostic reagent products. Geographically, it generates majority of the revenue from Mainland China.
Contact
No. 27 Chaoqian Road
Science and Technology Industrial Park
Changping District
Beijing102200
CHNT: +86 1080117700
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
471
Stocks News & Analysis
stocks
Undervalued Aussie e-commerce winner
Shares attractive due to near term profit margin increase and structural growth.
stocks
Our view on oil prices after Maduro is deposed
We’ve revisited our oil price assumptions after the news from Venezuela.
stocks
Nvidia: Full steam ahead with an impressive array of announcements at CES 2026
Our view of Nvidia at the current share price.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,018.00 | 21.50 | -0.24% |
| CAC 40 | 8,217.76 | 19.67 | -0.24% |
| DAX 40 | 25,063.12 | 170.92 | 0.69% |
| Dow JONES (US) | 49,296.62 | 165.46 | -0.33% |
| FTSE 100 | 10,047.56 | 75.17 | -0.74% |
| HKSE | 26,458.95 | 251.50 | -0.94% |
| NASDAQ | 23,586.27 | 39.10 | 0.17% |
| Nikkei 225 | 51,961.98 | 556.10 | -1.06% |
| NZX 50 Index | 13,715.02 | 51.44 | 0.38% |
| S&P 500 | 6,945.10 | 0.28 | 0.00% |
| S&P/ASX 200 | 8,695.60 | 27.90 | -0.32% |
| SSE Composite Index | 4,085.77 | 2.10 | 0.05% |